Deutsch English Français

Contact

EP4064862

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP4064862

EP4064862 - DESIGNED BACTERIAL COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 25.04.2025 Database last updated on 09.04.2026
Former	Request for examination was made Status updated on 02.09.2022
Former	The international publication has been made Status updated on 04.06.2021
Most recent event Tooltip	25.04.2025	Application deemed to be withdrawn	published on 28.05.2025 [2025/22]
Applicant(s)	For all designated states Seres Therapeutics, Inc. 200 Sidney Street Cambridge, MA 02139 / US
	[2022/40]
Inventor(s)	01 / MARTINEZ, Asuncion c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	02 / O'BRIEN, Edward J. c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	03 / SIMMONS, Sheri Lynn c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	04 / COOK, David c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	05 / HENN, Matthew R. c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	06 / FORD, Christopher B. c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	07 / BALASUBRAMANIAN, Divya c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	08 / PIÑA, Ambar c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	09 / DIAO, Liyang c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	10 / CHAFEE, Meghan c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	11 / VULIC, Marin c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	12 / NANDAKUMAR, Madhumitha 7 Garden Ct. Apt. 3 Belmont, California 94002 / US
	13 / DATTA, Sumon c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	14 / JAYARAMAN, Latta c/o Seres Therapeutics, Inc. 200 Sidney Street Cambridge, Massachusetts 02139 / US
	[2022/40]
Representative(s)	Garner, Stephen, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
	[2022/40]
Application number, filing date	20894012.2	25.11.2020
	[2022/40]
	WO2020US62440
Priority number, date	US201962941534P	27.11.2019 Original published format: US 201962941534 P
	[2022/40]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2021108728
	Date:	03.06.2021
	Language:	EN
	[2021/22]
	Type:	A1 Application with search report
	No.:	EP4064862
	Date:	05.10.2022
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.06.2021 takes the place of the publication of the European patent application.
	[2022/40]
Search report(s)	International search report - published on:	US	03.06.2021
	(Supplementary) European search report - dispatched on:	EP	07.06.2024
Classification	IPC:	A23L33/135, A61K35/74, A61K35/741, A61P1/00	[2022/40]
	CPC:	A23L33/135 (EP,KR); A61K35/74 (EP,KR); A61K35/741 (EP,KR,US); A61P1/00 (EP,KR); A61P29/00 (KR); A61P35/00 (KR,US); (+) A61P37/00 (KR,US); C12N1/20 (KR); Y02A50/30 (EP) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/40]
Title	German:	DESIGN VON BAKTERIELLEN ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN	[2022/40]
	English:	DESIGNED BACTERIAL COMPOSITIONS AND USES THEREOF	[2022/40]
	French:	COMPOSITIONS BACTÉRIENNES ET LEURS UTILISATIONS	[2022/40]
Entry into regional phase	27.06.2022	National basic fee paid
	27.06.2022	Search fee paid
	27.06.2022	Designation fee(s) paid
	27.06.2022	Examination fee paid
Examination procedure	27.06.2022	Examination requested [2022/40]
	24.04.2023	Amendment by applicant (claims and/or description)
	20.12.2024	Date on which the examining division has become responsible
	03.01.2025	Application deemed to be withdrawn, date of legal effect [2025/22]
	20.01.2025	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2025/22]
Fees paid	Renewal fee
	27.06.2022	Renewal fee patent year 03
	14.11.2023	Renewal fee patent year 04
	11.11.2024	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X] WO2018117263 (UNIV KEIO et al.) [X] 1-15 * claims 102-104; sequence 26 *
		[X] WO2017091783 (SERES THERAPEUTICS INC et al.) [X] 1-13 * sequence 41 *
		[X] WO2018112371 (VEDANTA BIOSCIENCES INC et al.) [X] 1,2,4 * sequence 7 *
		[XP] WO2019227085 (SERES THERAPEUTICS INC et al.) [XP] 1-15 * claims 78-91; sequences 190-194, 310-312 *
		[XP] WO2020118054 (SERES THERAPEUTICS INC et al.) [XP] 1-15 * claim 48; sequence 192 *
		[E] WO2021055352 (VEDANTA BIOSCIENCES INC et al.) [E] 1-13 * sequence 7 *
	International search	[XY] US2019134107 (SZABADY ROSE L et al.) [X] 60, 62-65 * para [0009] *[Y] 1, 4/1
		[Y] US2019192581 (VON MALTZAHN GEOFFREY et al.) [Y] 1,4/1 * abstract; para [0017], [0047], [0078] *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.